The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a treatment for depression. A clinic in Denver is looking to help those ...

A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The ...

For those with major depression, there is a new treatment option - one that offers hope when patients are not responding to ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.